History
Arteriosclerosis is, quite literally, an umbrella term for “changes in which the arteries become hard and thick and lose their elasticity.” The form that most commonly causes problems in clinical practice today is atherosclerosis, in which a grease-like material builds up on the inner lining of blood vessels and narrows them, but arteriosclerosis also includes forms such as arteriolosclerosis, in which small blood vessels thicken, and Monckeberg arteriosclerosis, in which the middle layer of the vessel becomes calcified. In other words, arteriosclerosis is closer to an umbrella concept that groups together “several vascular changes that differ in cause and appearance.”
Historically, too, the hardening and calcification of arteries has long been observed at autopsy and dissection. Before the 20th century, however, it was difficult to examine the condition of blood vessels directly in living people, so clinicians often treated arteriosclerosis as “a disease guessed at only belatedly, after symptoms appear.” With the spread of the blood pressure monitor, the electrocardiogram (EKG), blood tests, and advances in imaging technology all coming together, arteriosclerotic disease began in earnest to be redefined as a “preventable chronic disease.”
In particular, as understanding of cholesterol and lipid metabolism deepened and the view took hold that arteriosclerosis is not simply a buildup of fat but a process of ongoing inflammation and immune response, prevention and treatment strategies changed greatly. Recent research shows a trend toward understanding the cellular and molecular mechanisms more precisely, and strategies to reduce cardiovascular events through risk factor management and drug therapy continue to advance.
Causes
Rather than “one cause producing one disease,” arteriosclerosis is a change that arises as the process of blood vessel injury and recovery repeats over a long period. Taking atherosclerosis, the most common form, as the main example, the risk increases when the endothelium, which lines the inside of the blood vessels, is continually irritated or damaged. Typical irritants are high blood pressure, smoking, diabetes, dyslipidemia, obesity, and chronic inflammatory conditions. When these factors overlap, the inner lining of the blood vessels becomes rough, and low-density lipoprotein cholesterol (LDL-C) in the blood can seep more easily into the vessel wall.
Lipids that enter the vessel wall are easily oxidized, and this process becomes an important starting point that triggers an immune response and sustains inflammation. Because of the inflammatory response, immune cells gather in the vessel wall, foam cells form as they try to engulf the lipids, and over time a “plaque” is formed together with a fibrous cap. As the plaque grows, the vessel gradually narrows and blood flow to the affected organ may become insufficient; a more dangerous situation is when the plaque ruptures or its surface erodes and a blood clot forms rapidly.
However, arteriosclerosis is not limited to atherosclerosis. In arteriolosclerosis, which is common in small blood vessels, high blood pressure and diabetes thicken the walls of small vessels and reduce their elasticity, which can cause chronic damage to organs (the kidneys, eyes, brain, and others). Distinguishing “which type of arteriosclerosis it is” helps in determining the cause and the treatment approach.
Genetic Epidemiology
Arteriosclerosis is very strongly influenced by lifestyle, but even among people living the same way, it progresses quickly in some and relatively slowly in others, so genetic factors play a part. If someone in the family has had a heart attack or stroke at a young age, one may suspect that arteriosclerosis could progress more quickly when the same risk factors are present. This is sometimes due to a specific “single gene,” but in most cases it appears as several genetic predispositions combining to raise overall vascular vulnerability.
Genetic factors are usually linked to the “risk factors themselves,” such as cholesterol metabolism, the inflammatory response, blood pressure regulation, and blood sugar metabolism. For example, in conditions such as familial hypercholesterolemia, in which low-density lipoprotein cholesterol (LDL-C) is congenitally very high, arteriosclerosis can progress rapidly even at a relatively young age.
Recent research emphasizes using genetic background not as “fate” but as grounds for identifying high-risk groups early and carrying out prevention more aggressively. Even with a genetic predisposition, the actual risk can be meaningfully lowered by managing controllable factors such as smoking, blood pressure, blood sugar, and body weight well. It is realistic to understand heredity not as something that “fixes” the risk, but as a “signal that gives early notice” of the need for prevention.
General Epidemiology
Arteriosclerosis is regarded worldwide as the group of chronic diseases that forms the largest basis of cardiovascular disease. The hardening and narrowing of the arteries itself progresses slowly, but the events that result from it (heart attack, angina, stroke, peripheral artery disease, and others) can be sudden and fatal. For this reason, arteriosclerosis is often described as “a disease that progresses silently and then reveals itself one day as a major event.” Its occurrence and progression increase with age, and progression speeds up when long-accumulated abnormalities of blood pressure, blood sugar, and lipids overlap with smoking and lack of exercise.
Which blood vessels are mainly affected is also epidemiologically important. When the coronary arteries are affected, chest pain or heart attack becomes the problem, and when the cerebral blood vessels and carotid arteries are affected, stroke or transient ischemic attack may appear as the problem. When the blood vessels of the legs are affected, intermittent claudication, in which the calves hurt while walking, can occur.
Arteriosclerosis is not a “single-organ disease” but a systemic vascular disease, so when it is found in one place, it is reasonable to evaluate other sites as well. An individual's actual risk depends more on how long and how severely factors such as high blood pressure, diabetes, smoking, and low-density lipoprotein cholesterol (LDL-C) have accumulated than on sex.
Pathogenesis
The core mechanism of arteriosclerosis is that the structure of the vessel wall changes in the course of repeated injury and recovery. Looking mainly at atherosclerosis, when the endothelium lining the vessel is exposed to irritants such as high blood pressure, smoking, high blood sugar, and high low-density lipoprotein cholesterol (LDL-C), the vessel enters a “state of subtle inflammation,” and lipids readily accumulate through the gaps into the inner part of the vessel wall (the intima). The accumulated lipids become targets of immune cells as they are oxidized, and foam cells form as immune cells gather and engulf the lipids. As foam cells and the inflammatory response persist, the vessel wall becomes thicker, fibrous tissue increases, and over time calcification may also occur.
It is more accurate to understand this process not simply as an “accumulation of debris” but as a chronic inflammatory process in which the immune response and oxidative stress are intertwined. As the plaque grows, the vessel lumen narrows and can create chronic insufficiency of blood flow; conversely, even if the plaque is not particularly large, if its surface becomes weak, rupture or erosion can occur and a blood clot (thrombus) can form rapidly.
Recent research emphasizes the view that factors such as cellular stress responses, immunometabolic regulation, and microRNAs (miRNA) may be involved in the progression and instability of plaques. From a layperson's perspective, it is enough to understand it as follows: “When an environment that damages blood vessels (blood pressure, blood sugar, lipids, smoking) persists for a long time, inflammation and fat build up in the vessel wall, and the result leads to narrowing or a thrombotic event.”
Symptoms
Arteriosclerosis may cause no symptoms for most of its course. This is because symptoms appear only when a vessel has narrowed to a certain degree, when blood flow becomes insufficient, or when it is suddenly blocked by a clot. For this reason, the symptoms of arteriosclerosis appear not so much as “symptoms of arteriosclerosis itself” but as “organ-specific symptoms of insufficient blood flow” produced by arteriosclerosis. When the blood vessels of the heart (the coronary arteries) are affected, angina-like features such as chest pain or chest pressure and shortness of breath during exercise can appear, and if a vessel is suddenly blocked, this can lead to a heart attack.
When the cerebral blood vessels or carotid arteries are affected, stroke symptoms such as sudden paralysis on one side, speech disturbance, and visual disturbance can appear, and these sometimes first appear as a transient ischemic attack that resolves after a few minutes to several tens of minutes. When the blood vessels of the legs are affected, intermittent claudication is common, in which pain in the calves or thighs develops while walking and improves with rest. As it progresses, the feet may become cold and wounds may heal poorly, and in severe cases this can lead to ulcers and gangrene.
Ultimately, because the symptoms of arteriosclerosis vary depending on “which blood vessel supplies which organ,” it is difficult to conclude that one is safe just because there are no symptoms. If there are many risk factors, it is important to assess and manage the risk even before symptoms appear.
Signs
The signs of arteriosclerosis are objective clues found on physical examination and testing. What is most commonly checked on physical examination is a vascular murmur (bruit) and reduced or asymmetric peripheral pulses. For example, if there is a lot of plaque or narrowing in the carotid artery, a bruit may be heard in the neck, and if the blood vessels of the legs narrow, the dorsalis pedis or posterior tibial artery pulses may become weak. In testing, the ankle-brachial index (ABI) is used as a representative functional indicator. A low ABI raises the likelihood of peripheral artery disease of the legs.
On imaging, plaque, calcification, and narrowing can be seen on vascular ultrasound or CT, and indicators such as the coronary artery calcium score (CAC) help estimate the overall plaque burden. Another important sign is “target organ damage.” Findings of ischemia on an electrocardiogram, reduced heart function on echocardiography, or traces of a past cerebral infarction on brain imaging suggest that arteriosclerosis is already affecting the organs.
Therefore, with arteriosclerosis, the full picture becomes visible only when one evaluates not just the blood vessels but also the function of the organs they supply and any complications. In blood tests, the basics are to identify risk factors through lipids, blood sugar, kidney function, and so on.
Screening
The purpose of screening for arteriosclerosis is “to find high-risk groups before symptoms develop and prevent events.” The most basic step is screening for risk factors. Risk is assessed based on information such as blood pressure, blood sugar, lipids (especially low-density lipoprotein cholesterol), smoking status, body weight and waist circumference, and family history. This can be done without special equipment and is the starting point for preventing arteriosclerosis. For specific sites, simple functional tests are helpful. If peripheral artery disease of the legs is suspected or the person is in a high-risk group, ABI measurement is a relatively simple yet useful screening method.
If carotid artery disease is suspected or the risk of stroke is high, carotid ultrasound can be used for screening. On the cardiac side, indiscriminate testing in people without symptoms is not always helpful, but in people at high risk, imaging indicators such as the coronary artery calcium score (CAC) are sometimes used to estimate the overall burden of arteriosclerosis. “Symptom screening” in daily life is also important. Symptoms such as pain in the calves that occurs while walking and improves with rest, chest pain during exercise, or sudden paralysis or speech disturbance require evaluation without delay.
Recent research emphasizes combining vascular imaging with risk factor information to stratify risk more precisely, but from a layperson's perspective, the key message is that “the more risk factors you have, the earlier and more consistently screening and prevention are needed.”
Diagnosis
The diagnosis of arteriosclerosis proceeds by confirming risk factors and symptoms, looking for clues of reduced blood flow on physical examination, and confirming the location and severity of lesions with functional tests and imaging. First, the medical history checks for smoking, high blood pressure, diabetes, dyslipidemia, family history, exercise habits, and dietary habits, and asks whether there are symptoms of organ ischemia such as chest pain, pain on walking, or neurological symptoms. On physical examination, blood pressure (including the difference between the two arms), pulses, skin condition, vascular bruits, and so on are checked. As for tests, blood tests (lipids, blood sugar, kidney function) are basic, and they are important for setting the cause and treatment goals.
Imaging is chosen according to the site. Carotid ultrasound evaluates plaque and narrowing, and CT angiography (CTA) or MR angiography (MRA) identifies the location and extent of narrowing. The coronary arteries are evaluated with coronary CT or, if necessary, coronary angiography. With arteriosclerosis, “where and how much it has narrowed” is important, but so is “how much that narrowing actually reduces blood flow.”
Recent research shows that more sophisticated imaging techniques and risk assessments are advancing, but in practice it is important to appropriately select only the tests needed according to symptoms and risk level.
Treatment
Treatment of arteriosclerosis can be broadly divided into lifestyle modification, drug therapy for risk factors, and, when necessary, procedures and surgery. Lifestyle modification is fundamental at every stage. Quitting smoking, regular exercise, weight control, a diet that reduces salt and saturated fat and centers on vegetables, fruits, and fish, and refraining from heavy drinking help slow the progression of vascular disease. In particular, because smoking directly damages blood vessels and promotes blood clots, quitting smoking has a large effect. Drug therapy varies according to the risk factors and lesions. In lipid control, drugs such as statins are widely used as a key treatment that lowers low-density lipoprotein cholesterol (LDL-C) and reduces the risk of events.
Blood pressure control is an important treatment that reduces vascular damage, and diabetes control can lower the risk of both microvascular and macrovascular complications. When a vessel has already narrowed severely and is causing organ ischemia, or when the risk of an acute event is high, a procedure or surgery may be needed. Balloon dilation and stent placement (angioplasty) are methods of widening narrowed vessels, and surgery to create a bypass (coronary artery bypass surgery) or endarterectomy may also be considered depending on the situation.
Recent research shows advances such as the diversification of lipid-lowering therapy, inflammation-targeting treatments, and the use of precision imaging, but from a layperson's perspective, the broad framework of treatment is: “lifestyle plus consistent management of blood pressure, blood sugar, and lipids, and direct treatment of the blood vessels if necessary.”
Prognosis
The prognosis of arteriosclerosis depends greatly not only on “how bad the blood vessels are now” but also on “how well it is managed from now on.” Arteriosclerosis itself progresses slowly, but if a plaque becomes unstable or a blood clot forms, it can appear as a sudden event. Therefore, the most important factors determining prognosis are risk factor control (blood pressure, blood sugar, LDL-C, quitting smoking), medication adherence, and a rapid response when symptoms occur. In addition, because arteriosclerosis is a systemic disease, when disease is confirmed at one site, it is highly likely to be present at other sites as well.
Lowering low-density lipoprotein cholesterol (LDL-C) and controlling blood pressure through treatment can meaningfully reduce the risk of events, and even in people who already have the disease, it can reduce recurrence and worsening. Conversely, if smoking continues or diabetes and high blood pressure are not controlled, progression speeds up and can lead to serious outcomes such as heart attack, stroke, and lower limb amputation.
Recent research emphasizes that inflammation and the immune response can affect prognosis, but in practical terms, “consistently reducing controllable factors” is the greatest strategy for improving prognosis. Prognosis management should not be about “looking at only one organ,” but about lowering systemic vascular risk as a whole.
Prevention
Prevention of arteriosclerosis is divided into primary prevention (keeping it from developing in the first place) and secondary prevention (preventing worsening and recurrence in people who already have it). The most important pillar is risk factor management. Keeping blood pressure within the normal range, consistently managing blood sugar if you have diabetes, and lowering low-density lipoprotein cholesterol (LDL-C) are the core of prevention. For smokers, quitting smoking is the most important preventive measure, and losing weight and regularly walking or doing aerobic exercise are helpful. For diet, reducing saturated and trans fats and maintaining a pattern centered on vegetables, fruits, whole grains, and fish is beneficial for vascular health.
In addition, if there are coexisting conditions that increase the risk of arteriosclerosis, such as sleep apnea, chronic kidney disease, or chronic inflammatory diseases, these must be managed as well. For people with a strong family history or high risk at a young age, early screening and early treatment may be important. In secondary prevention, it is important not to stop medications on your own, to track levels regularly, and to be evaluated without delay if symptoms change.
Recent research shows that new approaches such as inflammation control, targeted therapy, and precision risk assessment are advancing alongside lipid lowering, but the core of prevention is still simple. “Reducing the environment that damages blood vessels (quitting smoking, managing blood pressure, blood sugar, and lipids) and maintaining a lifestyle that protects the blood vessels over the long term” is the most realistic and powerful way to prevent arteriosclerosis.